DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Vista Pharmaceuticals Ltd (VISTAPH) share price today?

Vista Pharmaceuticals Ltd (VISTAPH) is trading at ₹6.1 on the BSE, down 2.71% on the day. Source: DocStoX.

What is the PE ratio of Vista Pharmaceuticals Ltd?

Vista Pharmaceuticals Ltd has a price-to-earnings (PE) ratio of -2.9 in the Healthcare sector.

What is the market capitalisation of Vista Pharmaceuticals Ltd?

Vista Pharmaceuticals Ltd has a market capitalisation of approximately ₹38 crore.

Is Vista Pharmaceuticals Ltd a profitable company?

Vista Pharmaceuticals Ltd generates a return on equity of -33.1% with a net profit margin of -223.4%. That is a modest return on shareholder capital.

What is the 52-week high and low of VISTAPH?

Vista Pharmaceuticals Ltd (VISTAPH) has traded between ₹5.32 and ₹10.1 over the past 52 weeks, against a current price of ₹6.1.

Vista Pharmaceuticals Ltd

₹6.10▼ -0.17 (-2.71%)

VISTAPH·BSE·Healthcare

Market Cap

37.61 Cr

PE Ratio

-2.90

Volume

2,220

Day High - Low

6.40 - 6.00

52W High-Low

10.10 - 5.32

₹6.10▼ -0.17 (-2.71%)

Market Cap37.61 Cr

PE Ratio-2.90

Volume2,220

Day High - Low6.40 - 6.00

52W High-Low10.10 - 5.32

Vista Pharmaceuticals Ltd (VISTAPH): company summary

The company's business is deteriorating, with annual revenue falling 46.4% and annual net profit worsening from a loss of ₹5 crore to ₹12 crore.

Vista Pharmaceuticals Ltd (VISTAPH) is a micro-cap Healthcare company valued at ₹38 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move: Vista Pharmaceuticals Ltd last traded at ₹6.1, down 2.71% on the day.
Recent developments: 2026-06-30: The company reported a net loss of ₹1 crore for the latest quarter, matching the previous quarter's loss but with revenue dropping to zero. 2026-03-31: The company's financial year ended with a net loss of ₹12 crore, a widening from the prior year's loss of ₹5 crore.
Financial performance: The company's business is deteriorating, with annual revenue falling 46.4% and annual net profit worsening from a loss of ₹5 crore to ₹12 crore. The latest quarter saw revenue collapse to ₹0 crore, a 100.0% drop from the same quarter a year earlier, while the net loss remained flat at ₹1 crore.
Valuation multiples: A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 0.95 times book value.
Things to watch: The company's net profit margin has deteriorated to -223.4%, a 177.2 percentage point drop from the prior year. The latest quarter's revenue collapsed to zero, and the net loss remained flat despite a 100.0% decline in revenue. The stock is 37.9% below its 52-week high.
Where it stands: The company's financials show significant deterioration, with annual net profit worsening and revenue collapsing in the latest quarter. The net loss remained flat despite a 100.0% drop in revenue, and the stock is 37.9% below its 52-week high.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score

2.5/10

Poor

Fair Value

ROE

-33.10%

Weak

P/E

-2.90x

Loss-making

Debt / Equity

0.27

Low

Industry

Healthcare

Pharmaceuticals

Overall View

Mixed

Price performance

Day₹6.00

₹6.40

52W₹5.32

₹10.10

DocStoX take

Supported by growth (7.5) and risk (6.5), but held back by quality (0.0). Growth looks strong at 7.5, but that is offset by quality at 0.0 and momentum at 0.2. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence

2.5

/10

Poor

Quality

Weak

ROE -33.1%

Valuation

Fair

P/B 0.9× on assets (no earnings to value)

Growth

Strong

Revenue +40.1% 5Y CAGR

Risk

Moderate

D/E 0.27

Momentum

Weak

16% of 52-week range

DocStoX research

Our verdict

Fairly Valued

Fair value not available

Current price

₹6

Upside / Downside

—

Implied CAGR

—

Priced in by the market

Uncertainty

—

Est. confidence

At a glance

Market Cap

₹38 Cr

52W High / Low

₹10 / ₹5

Dividend Yield

0.00%

Promoter Holding

21.19%

EPS (TTM)

₹-1.96

Book Value

₹5.92

Key highlights

Revenue compounding 40% a year
Loss-making — no meaningful P/E
Loss-making in some of the last 5 years

1 Positive4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Explore Vista Pharmaceuticals Ltd’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

Vista Pharmaceuticals Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

SUN PHARMACEUTICAL IND L DIVI S LABORATORIES LTD TORRENT PHARMACEUTICALS L LAURUS LABS LIMITED ZYDUS LIFESCIENCES LTD APOLLO HOSPITALS ENTER. L CIPLA LTD DR. REDDY S LABORATORIES AUROBINDO PHARMA LTD MANKIND PHARMA LIMITED LUPIN LIMITED MANIPAL HEALTH ENTERPRI L

Compare Vista Pharmaceuticals Ltd with peers

Vista Pharmaceuticals Ltd vs SUN PHARMACEUTICAL IND L Vista Pharmaceuticals Ltd vs DIVI S LABORATORIES LTD Vista Pharmaceuticals Ltd vs TORRENT PHARMACEUTICALS L Vista Pharmaceuticals Ltd vs LAURUS LABS LIMITED Vista Pharmaceuticals Ltd vs ZYDUS LIFESCIENCES LTD Vista Pharmaceuticals Ltd vs APOLLO HOSPITALS ENTER. L

Related tools & concepts

Value Vista Pharmaceuticals Ltd with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earnings Return on Equity (ROE)Profitability ROCECapital efficiency Debt to EquityLeverage P/B RatioPrice to book Net Profit MarginBottom-line efficiency DCF / Intrinsic ValueEstimate fair value CAGR CalculatorAnnualised return Dividend YieldIncome on price Position SizeRisk-based sizing Brokerage CalculatorCharges on a trade SIP CalculatorSystematic investing

Explore further

VISTAPH newsLatest coverage & filings Open screenerFilter the whole market